Solute carrier family 2 member 1 (SLC2A1), commonly referred to as glucose transporter protein type 1, has been consistently associated with the occurrence and prognosis of pancreatic cancer in numerous studies 35-37. The gene discussed is SLC2A1; the disease is familial pancreatic carcinoma.